Zurich University of Applied Sciences   Report issue

Academic/Hospital Phase 4
Founded: Winterthur Switzerland (2007)

Organization Overview

First Clinical Trial
2007
NCT00572767
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Eling DeBruin | Markus Wirz | Reha Rheinfelden | University of Applied Science Zurich | Zurich University of Applied Sciences

Active Ingredients

Drugs in Phase 4 Trials (2)

amphetamine (Adderall) (1 trial)

glucose (1 trial)

Drugs in Other Trials (1)

iron sulfate (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Stroke (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3